MoneyWorks4Me

With no major difference for the quarter endedJune 2022 , the total revenue stood at Rs. 7294.60  millions.Profit saw a slight increase of 8.47%to Rs. 1156.30  millions from Rs. 1066.00 millions.Operating profit for the quarter ended June 2022 rose to 1757.20 millions as compared to 1634.70 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 7294.60 7018.40 3.94 7294.60 7018.40 3.94 32175.10 29204.70 10.17
Other Income 277.90 317.30 -12.42 277.90 317.30 -12.42 762.20 1101.90 -30.83
PBIDT 1757.20 1634.70 7.49 1757.20 1634.70 7.49 8320.50 7079.60 17.53
Interest 6.80 7.90 -13.92 6.80 7.90 -13.92 19.90 35.30 -43.63
PBDT 1750.40 1626.80 7.60 1750.40 1626.80 7.60 8416.40 5318.30 58.25
Depreciation 158.20 175.40 -9.81 158.20 175.40 -9.81 681.90 786.00 -13.24
PBT 1592.20 1451.40 9.70 1592.20 1451.40 9.70 7734.50 4532.30 70.65
TAX 435.90 385.40 13.10 435.90 385.40 13.10 3968.70 1665.40 138.30
Deferred Tax -34.70 -34.80 -0.29 -34.70 -34.80 -0.29 -105.00 78.70 -233.42
PAT 1156.30 1066.00 8.47 1156.30 1066.00 8.47 3765.80 2866.90 31.35
Equity 1694.10 1694.10 0.00 1694.10 1694.10 0.00 1694.10 1694.10 0.00
PBIDTM(%) 24.09 23.29 3.42 24.09 23.29 3.42 25.86 24.24 6.68
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..